Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TUMOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT05062447
What this trial is testing

Adaptive and Maladaptive Emotions in Patients With Cancer: Identification of Indicators

Who this might be right for
Adaptation, Emotional
Amsterdam UMC, location VUmc 134
Testing effectiveness (Phase 2)Study completedNCT04992949
What this trial is testing

Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm

Who this might be right for
Acute Myeloid LeukemiaMyeloproliferative Syndrome
French Innovative Leukemia Organisation 42
Testing effectiveness (Phase 2)Study completedNCT00005649
What this trial is testing

Paclitaxel and Capecitabine in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche
Testing effectiveness (Phase 2)WithdrawnNCT04834349
What this trial is testing

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaUnresectable Head and Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT06491238
What this trial is testing

Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
HealthPartners Institute 20
Testing effectiveness (Phase 2)WithdrawnNCT06085638
What this trial is testing

Phase I/II Study of SY-1425 (Tamibarotene) in Combination With Azacitidine and Venetoclax for Patients With Chronic Myelomonocytic Leukemia

Who this might be right for
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
Not applicableUnknownNCT06069648
What this trial is testing

Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening

Who this might be right for
Cervical Cancer
Chinese University of Hong Kong 270
Not applicableStudy completedNCT04089748
What this trial is testing

Basal Tumours in Bladder Cancer, Response to chemoTherapy

Who this might be right for
Bladder CancerChemotherapy Effect
University Hospital, Rouen 293
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Not applicableLooking for participantsNCT06966778
What this trial is testing

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

Who this might be right for
Localized Prostate CancerPostoperative Urinary Incontinence
National Taiwan University Hospital 135
Not applicableUnknownNCT04721184
What this trial is testing

Impact of Low Muscle Mass in HNC Treated With Immunotherapy

Who this might be right for
Head and Neck Small Cell CarcinomaSarcopenia
Institut Català d'Oncologia 120
Early research (Phase 1)Study completedNCT01051284
What this trial is testing

Gemcitabine and Cyberknife Radiation Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Georgetown University 14
Early research (Phase 1)Active Not RecruitingNCT03502733
What this trial is testing

Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid Neoplasm+1 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT00382733
What this trial is testing

Oral Topotecan to Treat Recurrent or Persistent Solid Tumors

Who this might be right for
Tumors
Accelerated Community Oncology Research Network 26
Not applicableUnknownNCT03621852
What this trial is testing

Prospective Evaluation of the Diagnostic Efficacy of a EUS Guided FNB Needle (AQUIRE®)

Who this might be right for
Tumors of the PancreasSubmucosal Tumor of Gastrointestinal Tract (Disorder)Lymph Node Disease
Philipps University Marburg 40
Not applicableUnknownNCT06471452
What this trial is testing

To Live Better After Breast Cancer Treatment

Who this might be right for
Breast Cancer Survivorship
Karolinska Institutet 40
Very early researchUnknownNCT04186052
What this trial is testing

Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma

Who this might be right for
Multiple Myeloma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Not applicableNot Yet RecruitingNCT05440747
What this trial is testing

Treatment Free Remission (TFR) in CML Patients （CML-CP）Study

Who this might be right for
Chronic Myeloid LeukemiaTreatment-free Remission
Guangdong Provincial People's Hospital 203
Early research (Phase 1)Looking for participantsNCT06883149
What this trial is testing

PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor

Who this might be right for
Solid TumorAdult
Chinese PLA General Hospital 25
Early research (Phase 1)Study completedNCT04857138
What this trial is testing

Evaluate Safety, Pharmacokinetics and Anti-Tumor Activity of RO7300490, as Single Agent or in Combination With Atezolizumab in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Hoffmann-La Roche 80
Next Page